FibroBiologics, Inc. (FBLG)
CIK 1958777 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for FibroBiologics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Oct 19, 2026 | EFFECT | 9999999995-26-003284 |
| Oct 19, 2026 | EFFECT | 9999999995-26-003282 |
| Oct 13, 2026 | POS AM | 0001193125-26-420449 |
| Oct 13, 2026 | D | 0001493152-26-046663 |
| Oct 13, 2026 | POS AM | 0001193125-26-420437 |
| Oct 8, 2026 | 8-K | 0001193125-26-418065 |
| Sep 18, 2026 | 8-K | 0001193125-26-395511 |
| Sep 17, 2026 | SCHEDULE 13D | 0001493152-26-043112 |
| Sep 16, 2026 | D | 0001493152-26-042792 |
| Sep 15, 2026 | 4 | 0001493152-26-042794 |
| Sep 15, 2026 | 8-K | 0001193125-26-391310 |
| Sep 9, 2026 | DEFA14A | 0001193125-26-386485 |
| Sep 1, 2026 | 3 | 0001493152-26-041112 |
| Aug 24, 2026 | 8-K | 0001193125-26-362027 |
| Aug 14, 2026 | SCHEDULE 13G | 0001172661-26-003577 |
| Jul 31, 2026 | DEF 14A | 0001193125-26-326818 |
| Jul 31, 2026 | 10-Q | 0001193125-26-328454 |
| Jul 24, 2026 | 8-K | 0001193125-26-316067 |
| Jul 17, 2026 | PRE 14A | 0001193125-26-307822 |
| Jul 16, 2026 | 3 | 0001493152-26-033509 |
| Jul 16, 2026 | EFFECT | 9999999995-26-002341 |
| Jul 16, 2026 | 424B3 | 0001193125-26-306114 |
| Jul 10, 2026 | S-3 | 0001193125-26-299884 |
| Jul 9, 2026 | 8-K | 0001193125-26-299290 |
| Jun 29, 2026 | D | 0001493152-26-031095 |